Kelly Bliss - Mar 19, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, U.S. Group Health
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 19, 2025
Transactions value $
-$79,775
Form type
4
Date filed
3/21/2025, 04:19 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +19.4K +54.86% 54.9K Mar 19, 2025 Direct F1
transaction TDOC Common Stock Sale -$79.8K -9.47K -17.26% $8.42 45.4K Mar 20, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -19.4K -33.33% $0.00 38.9K Mar 19, 2025 Common Stock 19.4K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.